The development of highly selective or isoform-specific inhibitors will reduce side effects and is an important goal for the near future
Obesity is a long-term condition where weight can fluctuate over time, including periods of regain
In: Beger, Warshaw, Carr-Locke, Russel, Bchler, Neoptolomos, Sarr, Hrsg., The Pancreas A Clinical Handbook
Phase 2 trial data suggest early appetite changes may emerge within the first two to four weeks, with measurable weight loss typically becoming apparent between weeks four and twelve
Pharmaceuticals (Basel, Switzerland)
It may mean the onboarding process failed, the dose was too aggressive, the patient never got a clear protocol, or the support system around the medication was too thin